Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05667324
PHASE4

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Sponsor: University of Florida

View on ClinicalTrials.gov

Summary

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the sphenopalatine ganglion using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Official title: Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2023-04-12

Completion Date

2025-02-28

Last Updated

2026-04-27

Healthy Volunteers

No

Interventions

DRUG

Ropivacaine

A single injection into the pterygopalatine fossa bilaterally of 0.5% ropivacaine at a dose of 20 mg (each side)

DRUG

Dexamethasone

Plus 4 mg dexamethasone

DRUG

Placebo

A single injection into the pterygopalatine fossa bilaterally of a balanced crystalloid intravenous solution (4 ml of normal saline)

Locations (1)

UF Health of University of Florida

Gainesville, Florida, United States